enVVeno Medical Corp (NVNO)
5.00
+0.03
(+0.60%)
USD |
NASDAQ |
May 10, 16:00
4.95
-0.05
(-1.00%)
Pre-Market: 20:00
enVVeno Medical Free Cash Flow (Quarterly): -3.559M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.559M |
December 31, 2023 | -4.977M |
September 30, 2023 | -4.216M |
June 30, 2023 | -4.584M |
March 31, 2023 | -5.114M |
December 31, 2022 | -3.865M |
September 30, 2022 | -4.497M |
June 30, 2022 | -3.982M |
March 31, 2022 | -3.39M |
December 31, 2021 | -3.167M |
September 30, 2021 | -2.385M |
June 30, 2021 | -2.798M |
March 31, 2021 | -3.866M |
December 31, 2020 | -2.641M |
September 30, 2020 | -2.617M |
Date | Value |
---|---|
June 30, 2020 | -1.442M |
March 31, 2020 | -1.157M |
December 31, 2019 | -1.636M |
September 30, 2019 | -1.522M |
June 30, 2019 | -1.607M |
March 31, 2019 | -1.495M |
December 31, 2018 | -1.449M |
September 30, 2018 | -1.753M |
June 30, 2018 | -1.541M |
March 31, 2018 | -1.625M |
December 31, 2017 | -1.280M |
September 30, 2017 | -1.209M |
June 30, 2017 | -1.114M |
March 31, 2017 | -0.6096M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.114M
Minimum
Mar 2023
-1.157M
Maximum
Mar 2020
-3.151M
Average
-3.278M
Median
Free Cash Flow (Quarterly) Benchmarks
Align Technology Inc | 19.30M |
ThermoGenesis Holdings Inc | -2.235M |
NeuroOne Medical Technologies Corp | -3.846M |
SINTX Technologies Inc | -3.202M |
Nutriband Inc | -0.7674M |